Effect of Combined Androgen Blockade with an LHRH Agonist and Flutamide in One Severe Case of Male Exhibitionism

@article{Rousseau1990EffectOC,
  title={Effect of Combined Androgen Blockade with an LHRH Agonist and Flutamide in One Severe Case of Male Exhibitionism},
  author={L. Rousseau and Mark Couture and Andr{\'e} Ph. D. Dupont and Fernand Labrie and Nancy Couture},
  journal={The Canadian Journal of Psychiatry},
  year={1990},
  volume={35},
  pages={338 - 341}
}
A severe exhibitionist has been treated with the combination of an LHRH agonist and the antiandrogen flutamide in order to maximize androgen blocking and to control his severe deviant behaviour. The results obtained show that the androgen blockade ended his exhibitionistic behaviour and markedly decreased his sexual fantasies and activities, especially masturbation, without significant side effects. 
The Management of a Case of Treatment-Resistant Paraphilia with a Long-Acting LHRH Agonist*
  • R. Dickey
  • Psychology, Medicine
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1992
TLDR
A patient with multiple paraphilias who had been treated for several years with sex drive reducing agents with little effect on sexual activity or fantasy was offered treatment with long-acting leuprolide acetate, an LHRH agonist, which produced a marked decrease in all reported sexual thoughts and activities. Expand
Effect of a long‐lasting gonadotrophin hormone‐releasing hormone agonist in six cases of severe male paraphilia
TLDR
GnRHa treatment, which leads to reversible castration, may constitute a promising treatment of paraphilic behavior and may favor the possibility of concurrent psychotherapy. Expand
Treatment of Paraphilia with Luteinizing Hormone-Releasing Hormone Agonists
Up to now there have been no published results of therapy of paraphilia (for example, pedophilia or sadism) and sexual aggressive impulsiveness with luteinizing hormone-releasing hormone (LHRH)Expand
Treatment of paraphilia with luteinizing hormone-releasing hormone agonists.
TLDR
11 patients who were treated with the LHRH agonist Leuprolide Acetate over a period of 12 months showed no tendency toward sexually aggressive behavior and reported an evident reduction of penile erection, ejaculation, masturbation, sexually deviant impulsiveness, and fantasies. Expand
Leuprolide acetate for exhibitionism in huntington's disease
  • S. Rich, F. Ovsiew
  • Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 1994
We treated a patient with Huntington's disease and exhibitionism using leuprolide acetate (Lupron Depot, TAP Pharmaceuticals), a gonadotropin‐releasing hormone agonist. The result was elimination ofExpand
Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone.
TLDR
Continuous administration of triptorelin, a long-acting agonist analogue of gonadotropin-releasing hormone, together with supportive psychotherapy, may be an effective treatment for men with severe paraphilia. Expand
Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: A lifetime treatment?
Six patients with severe paraphilia were treated with a long-acting gonadotrophin hormone releasing hormone analogue (GnRH-a). In five cases, the antiandrogen treatment ended their deviant sexualExpand
Depot-Leuprolide Acetate for Treatment of Paraphilias: A Report of Twelve Cases
TLDR
Leuprolide acetate resulted in a significant suppression of deviant sexual interests and behavior as measured by self-report and was well tolerated, however, the three patients who were on long-term therapy developed bone demineralization, suggesting that this is a significant side effect of prolonged therapy. Expand
Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: A clinical case study
TLDR
The recent development of LHRH (luteinizing hormone-releasing hormone) agonists and experience gained during their use in the treatment of prostatic carcinoma, have suggested that they might be helpful in reducing libido in some sexual offenders. Expand
Sex Hormones, Neurotransmitters, and Psychopharmacological Treatments in Men with Paraphilic Disorders
TLDR
The primary objective of this article is to examine and review data on the efficacy and tolerability of the testosterone-lowering agents medroxprogesterone acetate, cyproteroneacetate, and leuprolide acetate. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence.
TLDR
Six subjects who were evaluated by semen analysis and hormone profile at two-week intervals during ten-week basal, 20-week treatment, and post-treatment periods lasting at least ten weeks produced reversible oligozoospermia without attendant change in potency. Expand
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.
TLDR
It is indicated that a combined hormonal therapy which neutralizes all androgenic influences on peripheral tissues is of potential benefit in prostatic cancer and should minimize the development of metastases and androgen-resistant cell clones. Expand
The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens.
Using attitudinal, behavorial, and physiological measures, the effects of cyproterone acetate and ethinyl estradiol on the sexual behavior of sexual offenders was assessed. The effects of the drugsExpand
Progestogens in the Treatment of Male Sex Offenders: A Review
  • A. J. Cooper
  • Psychology, Medicine
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1986
TLDR
Clinical observations suggest that the drugs are reasonably effective in suppressing libido and sexual arousal in men, but differ somewhat in their pharamcology. Expand
Sexuality and Antihormonal Therapy in Prostate Cancer
TLDR
Chemical castration can be achieved by the chronic administration of LHRH agonists with no side effects other than those due to hypoandrogenicity (Labrie et al. 1980,1982). Expand
Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders
TLDR
The results showed that self-report of arousal outside of a laboratory setting was unreliable as a measure of the drug effect and there appeared to be a significant reduction in the report of arousal to erotic stimuli while genital arousal decreased only slightly. Expand
Organic treatment for the male sexual offender.
  • J. Bradford
  • Medicine
  • Annals of the New York Academy of Sciences
  • 1988
TLDR
This paper discusses all three significant organic treatments for the sexual offender, including a detailed description of background material and related studies, as well as the appropriate use of the treatments in the various types of male sexual offenders. Expand
Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
TLDR
Single daily injection of GnRH-A and T failed to predictably induce azoospermia in normal men over the 16-week treatment period, anticipating that addition of androgen would prevent agonist-induced changes in libido. Expand
Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration
TLDR
The findings suggest that such combined androgen blockade could be beneficial for the treatment of sex offenders because of the treatment's excellent tolerance. Expand
Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone.
TLDR
Heterogeneity of sperm density profiles still persists for reasons that are not yet clear, and continuous infusion of 500 micrograms of LHRHA daily for 16 weeks induced desensitization of the pituitary, loss of LH bioactivity, and decreases of FSH and testosterone. Expand
...
1
2
...